実験的肝不全モデルにおける脳内モノアミン代謝異常に関する研究
スポンサーリンク
概要
- 論文の詳細を見る
Studies were conducted to investigate the metabolism of monoamines, in particular that of norepinephrine (NE), in the brain of rats with hepatic failure. Hepatic failure was induced in rats by either acute ischemic hepatic failure (AIHF) or portacaval anastomosis (PCS). Brain levels of NE and its metabolites including 3-methoxy-4-hydroxyphenylglycol (MHPG), the final metabolite of NE in the central nervous system, were determined by HPLC-voltammetry.<BR>The following results were obtained:<BR>1) AIHF rats showed significantly higher total-MHPG and lower NE levels in the brain as compared with controls.<BR>2) In AIHF rats, a significant negative correlation between NE and either phenylalanine (Phe) or tyrosine (Tyr), as well as a significant positive correlation between MHPG and Phe or Tyr were demonstrated in the brain.<BR>3) Altered NE and MHPG levels in the brain of AIHF rats were found to restore toward normal following the treatment with Fischer's solution.<BR>4) PCS rats showed significantly higher total-MHPG levels in the brain as compared with controls, while no significant change was observed in NE level.<BR>In conclution, the reduction of NE level in the brain of AIHF model appears to be caused, at least in part, by the enhanced catabolism of NE due to increased brain contents of Tyr and Phe. This finding seems to support the Fischer's hypothesis of "false neurotransmitter" in hepatic encephalopathy.
著者
関連論文
- IMVP16/CBDCA療法を用いた自己末梢血幹細胞採取効率について
- W-1-4 当科における急性肝不全に対するアフェレシスの現状
- わが国における劇症肝炎の予後予測と肝移植の適応に関する多施設研究 : 日本急性肝不全研究会1996年肝移植適応ガイドライン策定の経緯
- 劇症肝炎における血漿交換療法の施行回数と肝炎の重症度に関する検討
- ビリルビン吸着と血漿交換が有効であった, メチマゾールによる高度肝内胆汁うっ滞の1例
- 経皮的エタノール注入療法(PEIT)後に腹腔内リンパ節転移をきたした小肝細胞癌の1例
- F-4 プロテアーゼインヒビターを用いたTGF-β活性化抑制を介する肝線維化治療薬の開発
- レチノイドによる肝癌発生の予防
- 10. 非環式レチノイドによる肝発癌抑制の作用機序-潜在肝癌細胞クローンの除去(clonal deletion)-
- 肝細胞癌硬膜転移による硬膜下血腫 : 臨床報告と文献的考察